https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/snyder-mark-drugs-roselle-inc-dba-mark-drugs-pharmacy-547409-02042021
Snyder Mark Drugs Roselle, Inc. d.b.a. Mark Drugs Pharmacy - 547409 - 02/04/2021 | FDA
Compounding Pharmacy/Adulterated Drug Products